Clearmind Biomedical
Medical Equipment Manufacturing • 
2F-8, No. 51, Taiwan, Province of China • 1-10 Employees
Company overview
| Headquarters | 2F-8, No. 51, Sec. 4, Zhongyang Rd., Tucheng Dist., New Taipei City, 236, TW |
| Phone number | +886222697417 |
| Websites | |
| NAICS | 3391 |
| Keywords | Minimally Invasive Surgery, ICH, Brain Surgery, Neurosurgical, Intracerebral Hemorrhage, Neuroendoscope |
| Founded | 2014 |
| Employees | 1-10 |
| Socials |
Key Contact at Clearmind Biomedical
Carrey Yang
Chief Executive Officer
Clearmind Biomedical Email Formats
Clearmind Biomedical uses 2 email formats. The most common is {first name} (e.g., john@theclearmindgroup.com), used 75% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@theclearmindgroup.com | 75% |
{first initial}.{last name} | j.doe@theclearmindgroup.com | 25% |
About Clearmind Biomedical
Established in 2014, ClearMind was created with backing from Y Combinator, one of the largest venture capital funds in the US. The founders of ClearMind were members of the Stanford-Taiwan Biomedical Fellowship Program, where they were inspired to build their company. The ClearMind vision is to save lives and help patients recover from otherwise debilitating brain injuries. We have received FDA clearance for our novel neuroendoscope, the Axonpen System, for illumination and visualization of intracranial tissue and fluids, and the controlled aspiration of tissue and/or fluid during surgery. Requiring only a narrow channel of 6.5mm through the skull for insertion into the brain, the steerable Axonpen combines excellent tissue visualization, suction, and irrigation functions. It has a working channel for use with accessory surgical devices. The Axonpen System is the first neuroendoscope to integrate all these capabilities into one, simple to use, minimally invasive operating platform. The Axonpen System supports a clinical shift in the minimally invasive removal of unwanted intracranial fluid and tissue, as commonly manifested in cases of intracerebral hemorrhage (ICH) and subdural hematomas. "One Doctor, One Hour" was the objective driving the ClearMind founders to create the Axonpen System. Meeting this objective allows a single surgeon to complete some critical surgeries in one hour, even at small-scale regional hospitals. More importantly, access to faster neurosurgical interventions after suffering a hemorrhagic stroke or other fluid producing injury has the potential to improve patient outcomes, including survival. Welcome to contact us to get more information!
Clearmind Biomedical revenue & valuation
| Annual revenue | $684,440 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $2,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Clearmind Biomedical has 4 employees across 4 departments.
Departments
Number of employees
Funding Data
Clearmind Biomedical has never raised funding before.
Clearmind Biomedical Tech Stack
Discover the technologies and tools that power Clearmind Biomedical's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Performance
Spain
United States
Frequently asked questions
4.8
40,000 users
